CClinicalTrials.gg
Status unknownNCT04645914Updated Nov 27, 2020

Influence of the Consumption of Conventional and Electric Cigarettes on Skin Circulation

An interventional study of Use of nicotine product (smoking/vaping) in Nicotine Dependence, Vaping and Smoking, sponsored by University Hospital Muenster. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-27.

Sponsored by University Hospital Muenster · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Nov 2020), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jul 2020, registered Nov 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
198
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The survey participants are divided into a smoking and non-smoking group. The smoker group is further divided according to the quantity and quality of nicotine ("normal" smoking, vaping). After reaching a steady state, the cutaneous blood flow at rest in the extremities of all participants is determined by Laser Doppler Imaging as a reference value. Laser Doppler Imaging produces images of the blood flow using perfusion units (PU). Subsequently, the perfusion is measured again after smoking/vaping. The difference in skin perfusion of the extremities is calculated (δ-Perfusion). All measurements are performed under controlled vital parameters (body temperature, systolic and diastolic blood pressure, heart rate) and controlled room temperature as well as 15-minute acclimatization of the patients.

Read the detailed description

After consenting to the study, the subjects are examined using Laser Doppler Camera.

The skin blood flow of the extremities is determined as a reference value. Laser Doppler Imaging produces images of the blood flow using the perfusion units (PU).

All measurements are taken under controlled vital parameters (body temperature, systolic and diastolic blood pressure, heart rate) and controlled room temperature as well as 15-minute acclimatization of the subjects.

For smokers or vapers, the perfusion is measured again after consuming a cigarette or an e-cigarette respectively. The difference of blood flow after smoking or vaping is calculated using both measures.

The total duration of the study per subject is approximately 25-30 minutes.

02

Conditions studied

  • Nicotine Dependence
  • Vaping
  • Smoking

Browse trials for

Keywords

  • Perfusion
  • Laser Speckle Contrast Analysis
  • Laser Doppler Camera
  • Nicotine
  • Smoking
  • Vaping
03

In context

Tobacco Use Disorder

968 studies on the registry are indexed under Tobacco Use Disorder; 128 are open to participants now.

This study's planned enrollment of 198 is above the median of 90 across 851 interventional studies indexed under Tobacco Use Disorder.

Browse Tobacco Use Disorder studies →

Lead sponsor

University Hospital Muenster is the lead sponsor of 189 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Healthy adult non-smokers, smokers, vapers

Exclusion criteria

Exclusion Criteria:

  • Adults with cardiopulmonary diseases
  • Pregnant women
  • Adults that participating in other surveys
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
198 participants (estimated)

Study arms

  • No intervention
    No smokers

    Healthy subjects who do not consume any nicotine products

  • Experimental
    Smokers/Vapers

    Healthy subjects who consume nicotine products

    Behavioral: Use of nicotine product (smoking/vaping)

Interventions

  • BehavioralUse of nicotine product (smoking/vaping)

    The smokers/vapers are consuming during the study one nicotine product of their own. The dose is the same as each individual is consuming regularly

06

What researchers measure

Primary outcomes

  1. Perfusion of the extremities for non-smokers, smokers and vapers

    The perfusion of the extremities will be measured in Perfusion Units. The Perfusion Units are calculated directly through the Laser Doppler Camera as a result of the examination.

    Time frame: 30 seconds

  2. Difference of perfusion after smoking/vaping

    The perfusion of the extremities will be measured after the consume of cigarettes/electronic cigarettes in Perfusion Units. The difference between the results of the examination before and after the consume of cigarettes/electronic cigarettes will be measured in Perfusion Units.

    Time frame: 30 seconds

Secondary outcomes

  1. Correlation of perfusion with age

    The age (years) will be controlled as a possible factor that influence the perfusion. Therefore the results in Perfusion Units measured through Laser Doppler Camera will be statistically analyzed taking into consideration the age in years of each subject.

    Time frame: 30 seconds

  2. Correlation of perfusion with gender

    The gender(male or female) will be controlled as a possible factor that influence the perfusion. Therefore the results in Perfusion Units measured through Laser Doppler Camera will be statistically analyzed taking into consideration the gender of each subject.

    Time frame: 30 seconds

  3. Correlation of perfusion with quantity of smoking/vaping

    The quantity of smoking/vaping (packet years/nicotine quantity for vaping) will be controlled as apossible factor that influence the perfusion. Therefore the results in Perfusion Units measured through Laser Doppler Camera will be statistically analyzed taking into consideration the quantity of smoking of each related subject.

    Time frame: 30 seconds

07

Study locations

1 of 1 sites recruiting
  • University Hospital Muenster
    Muenster, Nordrhein-Westfalen 48149, Germany
    • Andreas Kyriakou · Contact · andreaskyr93@gmail.com · 01636915011
    • Andreas Kyriakou, MD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04645914
Lead sponsor
University Hospital Muenster
Responsible party
Andreas Kyriakou (Vacular Surgery Resident, University Hospital Muenster) — Principal investigator
First posted
Nov 27, 2020
Start date
Jul 2, 2020
Primary completion
May 30, 2022 (estimated)
Completion
Dec 1, 2022 (estimated)
Last update
Nov 27, 2020

Study contacts

Andreas Kyriakou, MD
Contact
andreaskyr93@gmail.com
00491636915011
Alexander Oberhuber, Univ.-Prof.
Contact
alexander.oberhuber@ukmuenster.-de
00492518345782
Andreas Kyriakou, MD
principal investigator · University Hospital Muenster

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion